BioCentury's websites will be down for upgrades starting at 9 p.m. PDT on Monday, August 26. We expect the downtime to last no more than 6 hours, and we apologize for any inconvenience.

12:00 AM
 | 
Sep 27, 2010
 |  BC Week In Review  |  Company News  |  Sales & Marketing

HRA Pharma, Watson sales and marketing update

The companies expanded the territory of a February deal granting Watson exclusive rights to commercialize ulipristal acetate as an emergency contraceptive in the U.S. to include Canada. HRA...

Read the full 116 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >